Comparing Adoption of Breakthrough and "Me-too" Drugs among Medicare Beneficiaries: A Case Study of Dipeptidyl Peptidase-4 Inhibitors.
about
Comparing Adoption of Breakthrough and "Me-too" Drugs among Medicare Beneficiaries: A Case Study of Dipeptidyl Peptidase-4 Inhibitors.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Comparing Adoption of Breakthr ...... ptidyl Peptidase-4 Inhibitors.
@en
Comparing Adoption of Breakthr ...... ptidyl Peptidase-4 Inhibitors.
@nl
type
label
Comparing Adoption of Breakthr ...... ptidyl Peptidase-4 Inhibitors.
@en
Comparing Adoption of Breakthr ...... ptidyl Peptidase-4 Inhibitors.
@nl
prefLabel
Comparing Adoption of Breakthr ...... ptidyl Peptidase-4 Inhibitors.
@en
Comparing Adoption of Breakthr ...... ptidyl Peptidase-4 Inhibitors.
@nl
P2860
P1476
Comparing Adoption of Breakthr ...... eptidyl Peptidase-4 Inhibitors
@en
P2093
Inmaculada Hernandez
Yuting Zhang
P2860
P2888
P304
P356
10.1007/S12247-017-9277-X
P577
2017-02-13T00:00:00Z